SEC 13F Intelligence

Enhancing Capital LLC / BMY

Enhancing Capital LLC’s Bristol-Myers Squibb Co Position

Does Enhancing Capital LLC own Bristol-Myers Squibb Co (BMY)? Yes — 37.3K shares worth $2M (+1.68% of its 13F portfolio) as of Q1 2026.

Position Value
$2M
Q1 2026
Shares
37.3K
% of Portfolio
+1.68%
Quarters Held
10
currently held

Position History BMY

Reported value by quarter
Q4 ’21: $2MQ4 ’21Q1 ’22: $3MQ2 ’22: $3MQ2 ’22Q3 ’22: $3MQ4 ’24: $2MQ4 ’24Q1 ’25: $2MQ2 ’25: $2MQ2 ’25Q3 ’25: $2MQ4 ’25: $2MQ4 ’25Q1 ’26: $2Mfilingsflow.com
QuarterSharesValue% of Portfolio
Q1 202637.3K$2M+1.68%
Q4 202537.3K$2M+1.44%
Q3 202537.3K$2M+1.23%
Q2 202537.3K$2M+1.32%
Q1 202537.3K$2M+1.82%
Q4 202437.3K$2M+1.68%
Q3 202237.3K$3M+3.22%
Q2 202237.3K$3M+3.43%
Q1 202237.3K$3M+2.91%
Q4 202137.3K$2M+2.53%

Common-stock position only; options are excluded. Quarters where the fund filed no 13F or reported no position are absent. See Enhancing Capital LLC’s full portfolio or all institutional holders of BMY.